BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ciprofibrate
,
rs6983267
,
FOXP1
,
glucose metabolic process
,
Influenza
,
Neuron
,
Alcohol
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Siglec
Summary
General Info
Curated Studies
Most Correlated Studies
Tumor-infiltrating CD8+ T-cells from non-small cell lung cancer patients sorted for SIGLEC9
Macrophage adherent and non-adherent subsets uninfected or infected with HIV-1
Dendritic cell progenitors different subsets derived from bone marrow precursors
Leukocytes from fetal hearts with congenital heart block
Severe preeclampsia-related changes in gene expression
Explore Curated Studies Results
Literature
Most Relevant Literature
Modulation of immune cell reactivity with cis-binding Siglec agonists.
Transgenic mouse models to study the physiological and pathophysiological roles of human Siglecs.
Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towar…
Research progress on the role and clinical application of Siglecs in tumor immunity].
The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immun…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rh…
PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9
PET Imaging of Systemic Sclerosis Using FDG and 68Ga-DOTA-Siglec-9 9
Administration of Anti-siglec-6 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia…
"Don't Eat me" Signal in Hematological Malignancies: CD24 as New Target to Improve Anti-cancer Immun…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ